help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-129-4-1694
Endocrinology Vol. 129, No. 4 1694-1695
Copyright © 1991 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yalow, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yalow, R. S.

Remembrance Project: Origins of RIA

Rosalyn S. Yalow

Abstract

How did RIA begin? It was a serendipitous discovery in that it was a fallout from our investigations into what might be considered an unrelated study. Prompted by the suggestion of Dr. I. Arthur Mirsky that maturityonset diabetes might not be due to an absolute deficiency of insulin secretion but rather to its abnormally rapid degradation by an enzyme which Mirsky called insulinase (1), Dr. Solomon A. Berson and I attempted to study the metabolism of 131I-insulin after iv administration to diabetic and nondiabetic subjects (2). We observed a slower rate of disappearance of the 131I-insulin from the plasma of subjects who had been treated with insulin whether or not they were diabetic. We postulated that the slower disappearance was a consequence of the binding of labeled insulin to antibodies that had developed in response to administration of foreign proteinsi. i.e. animal insulins. We used a variety of physicochemical systems, including, among others, paper electrophoresis, ultracentrifugal analysis, and salting out methods, to prove that the protein that bound insulin in the plasma of insulin-treated subjects had the characteristics of an antibody, an IgG immunoglobulin. This concept was not acceptable to immunologists of the mid-1950s. The original paper describing these findings was rejected by Science and initially rejected by the Journal of Clinical Investigation (JCI). The JCI letter of rejection was subsequently published in my Nobel Lecture (3).

Received May 31, 1991.




This article has been cited by other articles:


Home page
EndocrinologyHome page
N. B. Schwartz
Perspective: Reproductive Endocrinology and Human Health in the 20th Century--A Personal Retrospective
Endocrinology, June 1, 2001; 142(6): 2163 - 2166.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society